PREGNANCY MULTIVITAMIN TABLET

Valsts: Kanāda

Valoda: angļu

Klimata pārmaiņas: Health Canada

Aktīvā sastāvdaļa:

BETA-CAROTENE; VITAMIN B1 (THIAMINE MONONITRATE); VITAMIN B2 (RIBOFLAVIN); NICOTINAMIDE; D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE); VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE); ASCORBIC ACID (ASCORBIC ACID); VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE); COPPER (COPPER GLUCONATE); IODINE (POTASSIUM IODIDE); IRON (FERROUS FUMARATE); MAGNESIUM (MAGNESIUM OXIDE); ZINC (ZINC OXIDE); FOLIC ACID; VITAMIN B12 (CYANOCOBALAMIN); VITAMIN D3 (CHOLECALCIFEROL); CALCIUM (CALCIUM CARBONATE)

Pieejams no:

JAMP PHARMA CORPORATION

ATĶ kods:

B03AE04

SNN (starptautisko nepatentēto nosaukumu):

IRON, MULTIVITAMINS AND MINERALS

Deva:

1.6MG; 3MG; 3.4MG; 20MG; 5MG; 10MG; 120MG; 13.8MG; 2MG; 0.15MG; 35MG; 50MG; 15MG; 1.1MG; 12MCG; 600UNIT; 300MG

Zāļu forma:

TABLET

Kompozīcija:

BETA-CAROTENE 1.6MG; VITAMIN B1 (THIAMINE MONONITRATE) 3MG; VITAMIN B2 (RIBOFLAVIN) 3.4MG; NICOTINAMIDE 20MG; D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE) 5MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10MG; ASCORBIC ACID (ASCORBIC ACID) 120MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8MG; COPPER (COPPER GLUCONATE) 2MG; IODINE (POTASSIUM IODIDE) 0.15MG; IRON (FERROUS FUMARATE) 35MG; MAGNESIUM (MAGNESIUM OXIDE) 50MG; ZINC (ZINC OXIDE) 15MG; FOLIC ACID 1.1MG; VITAMIN B12 (CYANOCOBALAMIN) 12MCG; VITAMIN D3 (CHOLECALCIFEROL) 600UNIT; CALCIUM (CALCIUM CARBONATE) 300MG

Ievadīšanas:

ORAL

Vienības iepakojumā:

15G/50G

Receptes veids:

Prescription

Produktu pārskats:

Active ingredient group (AIG) number: 1747661005; AHFS:

Autorizācija statuss:

APPROVED

Autorizācija datums:

2023-02-22

Produkta apraksts

_ Pregnancy Multivitamin Product Monograph_
_ Page 1 of 30_
PRODUCT MONOGRAPH
PR
PREGNANCY MULTIVITAMIN
Vitamin-Mineral Supplement Tablets for Prenatal/Postpartum Use
Oral, Blue Tablet (evening) contains 1.1 mg of Folic Acid
Multivitamins and other Minerals Including Combinations
JAMP Pharma Corporation
1310 rue Nobel
Boucherville, Quebec
J4B 5H3, Canada
Control No.: 252149
Date of Revision:
February 22, 2023
_ Pregnancy Multivitamin Product Monograph_
_ Page 2 of 30_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY PRODUCT INFORMATION
...............................................................................................................
3
INDICATIONS AND CLINICAL USE
....................................................................................................................
4
CONTRAINDICATIONS
.........................................................................................................................................
4
WARNINGS AND PRECAUTIONS
........................................................................................................................
4
ADVERSE REACTIONS
..........................................................................................................................................
6
DRUG INTERACTIONS
........................................................................................................................................
10
DOSAGE AND ADMINISTRATION
....................................................................................................................
15
OVERDOSAGE
......................................................................................................................................................
16
ACTION AND CLINICAL PHARMACOLOGY
...................................................................................................
17
STORAGE AND STABILITY
...........................................................................